Evaluation of the 'Colli-Pee', a first-void urine collection device for self-sampling at home for the detection of sexually transmitted infections, versus a routine clinic-based urine collection in a one-to-one comparison study design: efficacy and acceptability among MSM in Belgium
De Baetselier et al.
The finding, in our words
The Colli-Pee device achieved very good to almost perfect agreement with clinic collected urine for chlamydia, gonorrhoea and mycoplasma testing, and participants found it feasible and convenient for home sampling, supporting its use for frequent STI screening in at-risk groups.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
This randomised sub-study found return rates of 10.4% for Colli-Pee, 10.1% for FLOQSwabs and 7.4% for Evalyn-Brush. All devices yielded sufficient DNA with low invalid rates, but the authors noted the study was limited by low overall participation.
Hempel et al., Archives of gynecology and obstetrics · source ↗
In 498 women living with HIV, self-collected first-void urine and vaginal samples showed 78% high-risk HPV prevalence and good genotype concordance, kappa 0.64-0.78. Participants preferred the Colli-Pee device over the Evalyn Brush, supporting decentralised, patient-centric screening feasibility.
Madsen et al., Journal of medical virology · source ↗
Urine self-sampling for HPV showed non-inferior specificity to cervical samples, 85.19%, and found 96% of high-grade lesions. While acceptable, a survey of 1382 participants found 41.6% preferred conventional screening, showing the importance of offering choice in a decentralised, patient-centric programme.
Davies et al., The British journal of general practice : the journal of the Royal College of General Practitioners · source ↗
First-void urine collected with the Colli-pee device detected high-grade cervical precancer with 90.3% sensitivity, substantially better than the 73.4% sensitivity of standard-pot urine, and was acceptable to colposcopy attendees. The device achieved 92% relative sensitivity compared with clinician-collected cervical samples, showing promise for decentralised HPV screening.
Davies et al., BJOG : an international journal of obstetrics and gynaecology (paywalled) · source ↗
Among 515 women, 93% believed HPV self-sampling could improve screening uptake and 95% found instructions clear and felt confident, yet 41% still preferred clinician collection and 9-19% found it unpleasant. This shows urine-based screening with Colli-Pee is well accepted but not universally preferred, a crucial insight for patient-centric decentralised programmes.
De Pauw et al., Archives of public health = Archives belges de sante publique · source ↗